|
Drug |
Pharmacodynamics |
Pharmacokinetics |
Unwanted effects |
Clinical Use |
|
Calcium channel blockers: ·
Verapamil ·
Nifedipine ·
Diltiazem |
Mechanism of action: ·
Block entry of Ca2+ into autorhythmic & excitable
cells. ·
Cytoplasmic free Ca2+ determines contractility of cardiac
& smooth muscle. ·
Use dependence: more active receptor, greater efficacy of drugs. ·
Voltage dependence: different potency in different membrane
potentials. ·
Skeletal muscle is not affected. Vasculature: ·
Arterial vasodilation ·
Nifedipine > Diltiazem > Verapamil Nodal & conducting tissue: ·
Decrease rate of nodal discharge & conduction. ·
Prolong AV nodal refractory period. ·
Verapamil > Diltiazem Myocardium: ·
Decrease myocardial contractility. ·
Verapamil > Diltiazem. |
·
Well absorbed orally. ·
High protein binding (90%) ·
Extensively metabolized by the liver with active metabolites. ·
Short half-lives: 4-6hrs ·
Little excreted unchanged. ·
High first pass effect: verapamil (80%), diltiazem (45%), nifedipine
(40%) Verapamil: ·
(-) isomer 10 x active than (+) ·
Bioavailability of (-) isomer only 15% of (+) isomer Nidedipine: ·
Wide interindividual variability ·
Metabolized by CYP3A4 enzyme in liver. ·
Inhibited by ketoconazole, grapefruit |
Verapamil: ·
Constipation ·
Headache ·
Pruritus ·
Mild nausea ·
Nervousness ·
Peripheral edema ·
Hypotension Nifedipine: ·
Flushing ·
Palpitations ·
Headache ·
Hypotension ·
Peripheral edema ·
Compensatory tachycardia may precipitate angina Diltiazem: same as verapamil but lower incidence |
Angina pectoris: ·
All three are effective. ·
Dilation of coronary vessels improves perfusion. ·
Arterial vasodilation decreases afterload & decrease heart rate. ·
Decreased contractility decreases myocardial oxygen demand. Variant angina & peripheral vascular disease: ·
Nifedipine relieves coronary artery spasm in Printzmetal angina. ·
Also useful in Raynaud’s phenomenon. Hypertension: ·
Nifedipine has the greatest vasodilator & least cardiac effects. ·
Used in emergency treatment of severe hypertension. Congestive heart failure: ·
Arterial vasodilation decreases
afterload. ·
Higher doses produce suppression of cardiac contractility & heart
rate. Antiarrhythmia: ·
Effects of verapamil on AV nodal conduction useful in AV
tachyarrhythmias: ·
Paroxysmal supraventricular tachycardia ·
Wolff-Parkinson-White syndrome Ischaemic heart disease: ·
Prolong survival of ischaemic heart muscle by preventing damage due to
intracellular accumulation of Ca2+ in anoxia. Cardiac surgery: ·
Included in cardioplegic solutions used in cardiac surgery. Anticalcinotic vascular protection: ·
Useful in protecting vessel walls from damage by intracellular
accumulation of Ca2+. |
|
Nitrates: ·
Amyl nitrate ·
Glyceryl trinitrate ·
Isosorbide dinitrate
|
Mechanism of action: ·
Denitrated in smooth muscle to release NO. ·
NO activates guanylyl cyclase & increase cGMP which acitvates a
cGMP-dependent protein kinase. ·
Eventual dephosphorylation of myosin light chain kinase causes smooth
muscle relaxation. Desired effects: ·
Venodilation decreases venous return. ·
Arteriolar dilation decreases afterload.
|
·
Poor bioavailability ·
Sublingual administration for rapid action ·
Oral or transcutaneous route for longer duration. ·
Metabolites of glyceryl trinitrate & isosorbite dinitrate are active
after denitration. Administration: ·
Amyl nitrate: crushable ampoule for inhalation. ·
Rest: sublingual or chewable tablet. Onset of action: ·
Amyl nitrate: 10min ·
Glyceryl trinitrate: 30min ·
Isosorbide nitrate: chewable & sublingual – 1hr; oral substained
release – 6-12hr ·
Isosorbide-5-mononitrate (oral): 12hr
|
·
Orthostatic hypotension ·
Dizziness ·
Throbbing headache due to meningeal artery pulsations ·
Palpitations ·
Methaemoglobinemia Reflex tachycardia: ·
Due to compensatory increase in heart rate & contractility. ·
Reduces therapeutic effect by increasing oxygen demand & decreasing
perfusion time. Tolerance: ·
Tends to occur esp. with high doses of long-acting nitrates which give
steady plasma concentration. ·
Cross-tolerance between different nitrates. ·
Avoid using intermittent dosing.
|
Contraindicated in: ·
Ventricular outflow obstruction ·
Low output heart failure ·
Raised intracranial pressure ·
Glaucoma ·
Mitral valve prolapse Choice of preparation: ·
Sublingual glyceryl trinitrate is the most frequently used preparation
for relief of anginal symptoms because of its ease of administration &
rapid onset of action. ·
It is not suitable for maintenance therapy because of its short duration
of action.
|
|
ACE Inhibitors: ·
Captropril ·
Enalapril
|
·
Inhibits angiotensin-converting enzyme ·
ACE is bound to membrane of vascular endothelial cells. ·
It converts angiotensin I to angiotensin II & inactivates bradykinin ·
Lowers peripheral vascular resistance.
|
·
Well absorbed orally. Captopril: ·
Half-life: 3hrs ·
Metabolized to disulphide conjugates. ·
Less than 50% of an oral dose is excreted unchanged by kidneys. Enalapril: ·
A prodrug, de-esterified to active metabolite enalaprilat. ·
Peak concentration after 3-4hrs.
|
Captopril: ·
Bone marrow suppression ·
Neutropenia ·
Nephrotoxicity ·
Macular rash ·
Altered taste ·
Dry cough ·
Severe hypotension in hypovolemic patients Drug interactions: ·
Potassium-sparing diuretics: precipitate hyperkalemia
|
·
Effective blood pressure lowering in 70% of patients; up to 90% if used
with diuretics. ·
Initial hypotension may be substantial, hence first dose is usually
given at night. ·
Greater fall in blood pressure in high renin states but has effect even
in low renin states. Iosartan: ·
Competitive angiotensin I receptor antagonist ·
Short half-life: 2hrs ·
Active metabolite, non-competitive antagonist with longer half-life.
|
|
Vasodilators: ·
Hydralazine ·
Minoxidil ·
Diazoxide
|
Hydralazine: ·
May act through guanylate cyclase. ·
Arteriolar dilation ·
Increase heart rate & stimulation of renin-angiotensin-aldosterone
system Minioxidil: ·
Opening of K+ channels. ·
More potent than hydralazine Diazoxide: ·
Chemically similar to the thiazides. ·
No diuretic action ·
Tend to cause fluid retenion Sodium nitroprusside: ·
Cyanonitroso-complex of iron ·
Dilates both arteries & veins
|
Hydralazine: ·
Well absorbed orally ·
Bioavailability: 25% ·
Metabolized in part by acetylation, a pathway subject to genetic
polymorphism. ·
Half-life: 2-3hrs ·
Duration of effect: 6-8hrs Minoxidil: ·
Well absorbed orally ·
Metabolized by glucuronide conjugation ·
Not protein bound ·
Half-life: 4hrs ·
Duration of action: 1-3 days Diazoxide: ·
Extensively bound to plasma protein & vascular tissue. ·
Metabolized & excreted unchanged. Sodium nitroprusside: ·
Administered parenterally
|
Hydralazine: ·
Toxicity is more common in slow acetylators receiving high doses. ·
SLE-like syndrome ·
Arthralgia ·
Myalgia ·
Fever ·
Skin rash ·
Diarrhea ·
Constipation ·
Flushing Minoxidil: ·
Headache ·
Sweating ·
Excessive hair growth ·
Cardiotoxicity ·
Autoimmune reaction Diazoxide: ·
Hyperglycaemia ·
Hyperosmolarity Sodium nitroprusside: ·
Thiocyanate toxicity ·
Disorientation ·
Psychosis ·
Muscle spasms ·
Convulsions
|
Hydralazine: ·
Compensatory tachycardia & fluid retenion ·
Used in combination with a beta-blocker or a diuretic. Minoxidil: ·
Topical minoxidil is used to stimulate hair growth to counter baldness. ·
Compensatory effects more marked than hydralazine; must be combined with
a beta-blocker or diuretic. Diazoxide: ·
High efficacy arteriolar dilator used in hypertensive emergencies. ·
Administered parenterally with onset of hypotensive effect within 5
minutes & lasts for several hours. ·
Excessive dosing has resulted in stroke, angina or myocardial infarction
induced by profound hypotension. Sodium nitroprusside: ·
Administered by intravenous infusion & in hypertensive emergencies
its extremely rapid action & short duration of action require constant
titration of infusion rate against fall in blood pressure.
|
|
Central Sympathoplegics: ·
Methyldopa |
·
Reduce sympathetic outflow from vasopressor centers in the brainstem. ·
Methyldopa: taken up into central & peripheral adrenergic terminals
& converted to an a-receptor
agonist, a-methylnonepinephrine
|
Methyldopa: ·
Bioavailability: 25% ·
Extensive first-pass conjugation by GI mucosa. ·
Half-life: 2hrs ·
Limited maximal efficacy in lowering blood pressure. Clonidine: ·
Bioavailability: 75% ·
Half-life: 8-12hrs ·
Lipid-soluble: rapidly enters brain. ·
Given twice a day.
|
Methyldopa: ·
Overt sedation ·
Mental lassitude ·
Impaired mental concentration ·
Nighmares ·
Mental depression ·
Vertigo ·
Extrapyramidal signs ·
Lactation ·
Positive Coombs test Clonidine: ·
Dry mouth ·
Sedation ·
Mental depression ·
Tricyclic antidepressants block effects.
|
Methyldopa: ·
Useful in treatment of mild to moderately severe hypertension. ·
Lowers blood pressure chiefly by reducing peripheral vascular
resistance, with a variable reduction in heart rate & cardiac output. ·
Advantage: causes retention in renal vascular resistance. Clonidine: ·
Reduction of cardiac output due to decreased heart rate.
|
|
Ganglion-blocking agents:
|
Block stimulation of postganglionic autonomic neurons by acetycholine. |
·
Administered IV.
|
·
Orthostatic hypotension ·
Sexual dysfunction ·
Constipation ·
Urinary retention ·
Glaucoma ·
Blurred vision
|
·
Except trimethapan, drugs of this class are no longer used clinically
due to intolerable toxicities. ·
Hypertensive emergencies.
|
|
Adrenergic neuron-blocking agents: ·
Guanethidine |
·
Lower blood pressure by preventing normal physiologic release of
norepinephrine from postganglionic sympathetic neurons. Guanethidine: ·
Inhibits release of norepinephrine from sympathetic nerve endings. ·
Cause a gradual depletion of nonepinephrine stores in the nerve ending. Reserpine: ·
Blocks ability to transmitter vesicles to take up & store biogenic
amines.
|
Guanethidine: ·
Bioavailability is variable. ·
50% cleared by kidney. ·
Long half-life: 5 days. ·
Onset of effect is gradual with constant daily dosing. Reserpine:
|
Guanethidine: ·
Postural hypotension ·
Hypotension following exercise ·
Decreased blood flow to heart & brain ·
Shock ·
Delayed or retrograde ejaculation ·
Diarrhea ·
TCAs decrease effects Reserpine: ·
Sedation ·
Lassitude ·
Nightmares ·
Severe mental depression ·
Mild diarrhea ·
Gastrointestinal cramps
|
Guanethidine: ·
High maximal efficacy. ·
Mainstay of outpatient therapy of severe hypertension. Reserpine: ·
Lowers blood pressure by decreased cardiac output & decreased
peripheral vascular resistance.
|